Advertisement

Serum uric acid and risk of ischemic stroke: The ARIC Study

      Abstract

      Aims

      Since serum uric acid (UA) is strongly associated with cardiovascular risk factors, it has been debated whether serum UA is a stroke risk factor or whether UA may be simply “marking” subjects with other, causal risk factors. We therefore investigated the relation between UA and ischemic stroke in the Atherosclerosis Risk in Communities (ARIC) Study.

      Methods and results

      Of 15,792 ARIC participants, 13,413 who were free of recognized stroke or coronary heart disease (CHD) at baseline and had a baseline UA measurement were included in the analysis. We followed the participants for ischemic stroke incidence (N = 381) over 12.6 years. Although serum UA was independently and positively related to ischemic stroke incidence when we adjusted for age, sex, race, and education, the positive relation was weakened when additionally adjusted for possible confounding variables. The positive multivariate-adjusted association between serum UA and ischemic stroke was observed among subjects not using diuretics (adjusted relative hazard in the highest quartile versus the lowest: relative hazard (RH) = 1.49; 95% confidence interval (CI): 1.00–2.23) (P for trend: 0.02), but not among diuretic users (P for interaction: 0.08).

      Conclusion

      Our findings suggest that UA is an independent predictor of ischemic stroke among subjects not using diuretics, but that elevated UA itself may not cause ischemic stroke.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Johnson R.J.
        • Kang D.H.
        • Feig D.
        • et al.
        Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?.
        Hypertension. 2003; 41: 1183-1190
        • Rich M.W.
        Uric acid: is it a risk factor for cardiovascular disease?.
        Am J Cardiol. 2000; 85: 1018-1021
        • Brand F.N.
        • McGee D.L.
        • Kannel W.B.
        • Stokes 3rd, J.
        • Castelli W.P.
        Hyperuricemia as a risk factor of coronary heart disease: the Framingham study.
        Am J Epidemiol. 1985; 121: 11-18
        • Tomita M.
        • Mizuno S.
        • Yamanaka H.
        • et al.
        Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers.
        J Epidemiol. 2000; 10: 403-409
        • Mazza A.
        • Pessina A.C.
        • Pavei A.
        • et al.
        Predictors of stroke mortality in elderly people from the general population. The CArdiovascular STudy in the ELderly.
        Eur J Epidemiol. 2001; 17: 1097-1104
        • Wang J.G.
        • Staessen J.A.
        • Fagard R.H.
        • et al.
        Prognostic significance of serum creatinine and uric acid in older Chinese patients with isolated systolic hypertension.
        Hypertension. 2001; 37: 1069-1074
        • Longo-Mbenza B.
        • Luila E.L.
        • Mbete P.
        • Vita E.K.
        Is hyperuricemia a risk factor of stroke and coronary heart disease among Africans?.
        Int J Cardiol. 1999; 71: 17-22
        • Lehto S.
        • Niskanen L.
        • Ronnemaa T.
        • Laakso M.
        Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus.
        Stroke. 1998; 29: 635-639
        • Goldberg R.J.
        • Burchfiel C.M.
        • Benfante R.
        • et al.
        Lifestyle and biologic factors associated with atherosclerotic disease in middle-aged men. 20-Year findings from the Honolulu Heart Program.
        Arch Intern Med. 1995; 155: 686-694
        • Franse L.V.
        • Pahor M.
        • Di Bari M.
        • et al.
        Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP).
        J Hypertens. 2000; 18: 1149-1154
        • Niskanen L.K.
        • Laaksonen D.E.
        • Nyyssonen K.
        • et al.
        Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study.
        Arch Intern Med. 2004; 164: 1546-1551
        • Moriarity J.T.
        • Folsom A.R.
        • Iribarren C.
        • Nieto F.J.
        • Rosamond W.D.
        Serum uric acid and risk of coronary heart disease: Atherosclerosis Risk in Communities (ARIC) Study.
        Ann Epidemiol. 2000; 10: 136-143
        • Yusuf S.
        • Bosch J.
        Urate levels as a predictor of cardiac deaths: causal relation or mere association?.
        Eur Heart J. 2002; 23: 760-761
        • Culleton B.F.
        • Larson M.G.
        • Kannel W.B.
        • Levy D.
        Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study.
        Ann Intern Med. 1999; 131: 7-13
        • Nieto F.J.
        • Iribarren C.
        • Gross M.D.
        • Comstock G.W.
        • Cutler R.G.
        Uric acid and serum antioxidant capacity: a reaction to atherosclerosis?.
        Atherosclerosis. 2000; 148: 131-139
        • Reyes A.J.
        Cardiovascular drugs and serum uric acid.
        Cardiovasc Drugs Ther. 2003; 17: 397-414
        • Reyes A.J.
        • Leary W.P.
        The increase in serum uric acid induced by diuretics could be beneficial to cardiovascular prognosis in hypertension: a hypothesis.
        J Hypertens. 2003; 21: 1775-1777
        • Sakata K.
        • Hashimoto T.
        • Ueshima H.
        • Okayama A.
        • NIPPON DATA 80 Research Group
        Absence of an association between serum uric acid and mortality from cardiovascular disease: NIPPON DATA 80, 1980–1994. National Integrated Projects for Prospective Observation of Non-communicable Diseases and its Trend in the Aged.
        Eur J Epidemiol. 2001; 17: 461-468
        • De Leeuw P.W.
        • Thijs L.
        • Birkenhager W.H.
        • et al.
        • Systolic Hypertension in Europe (Syst-Eur) Trial Investigators
        Prognostic significance of renal function in elderly patients with isolated systolic hypertension: results from the Syst-Eur trial.
        J Am Soc Nephrol. 2002; 13: 2213-2222
        • The ARIC Investigators
        The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives.
        Am J Epidemiol. 1989; 129: 687-702
        • Eckfeldt J.H.
        • Chambless L.E.
        • Shen Y.L.
        Short-term, within-person variability in clinical chemistry test results. Experience from the Atherosclerosis Risk in Communities Study.
        Arch Pathol Lab Med. 1994; 118: 496-500
        • Warnick G.R.
        • Benderson J.M.
        • Albers J.J.
        Quantitation of high-density-lipoprotein subclasses after separation by dextran sulfate and Mg2+ precipitation.
        Clin Chem. 1982; 28: 1574
      1. National Heart, Lung, and Blood Institute. Atherosclerosis Risk in Communities (ARIC) Study. Operations manual no. 9: hemostasis determinations, version 1.0. Chapel Hill, NC: ARIC Coordinating Center, School of Public Health, University of North Carolina; 1987.

        • Wu K.K.
        • Papp A.C.
        • Patsch W.
        • et al.
        ARIC hemostasis study. II. Organizational plan and feasibility study.
        Thromb Haemost. 1990; 64: 521-525
        • Sharrett A.R.
        The Atherosclerosis Risk in Communities (ARIC) Study: introduction and objectives of the hemostasis component.
        Ann Epidemiol. 1992; 2: 467-469
      2. National Heart, Lung, and Blood Institute. Atherosclerosis Risk in Communities (ARIC) Study. Operations manual no. 10: clinical chemistry determinations, version 1.0. Chapel Hill, NC: ARIC Coordinating Center, School of Public Health, University of North Carolina; 1987.

        • Chambless L.E.
        • McMahon R.P.
        • Brown S.A.
        • et al.
        Short-term intraindividual variability in lipoprotein measurements: the Atherosclerosis Risk in Communities (ARIC) Study.
        Am J Epidemiol. 1992; 136: 1069-1081
        • Chambless L.E.
        • McMahon R.
        • Wu K.
        • et al.
        Short-term intraindividual variability in hemostasis factors: the ARIC Study.
        Ann Epidemiol. 1992; 2: 723-733
      3. National Heart, Lung, and Blood Institute. Atherosclerosis Risk in Communities (ARIC) Study. Operations manual no. 2: cohort component procedures, version 1.0. Chapel Hill, NC: ARIC Coordinating Center, School of Public Health, University of North Carolina; 1987.

        • Fuchs F.D.
        • Chambless L.E.
        • Whelton P.K.
        • Nieto F.J.
        • Heiss G.
        Alcohol consumption and the incidence of hypertension: the Atherosclerosis Risk in Communities Study.
        Hypertension. 2001; 37: 1242-1250
      4. National Heart, Lung, and Blood Institute. Atherosclerosis Risk in Communities (ARIC) Study. Operations manual no. 11: sitting blood pressure, version 1.0. Chapel Hill, NC: ARIC Coordinating Center, School of Public Health, University of North Carolina; 1987.

      5. National Heart, Lung, and Blood Institute. Atherosclerosis Risk in Communities Study (ARIC). Operations manual no. 5: electrocardiography, version 1.0. Chapel Hill, NC: ARIC Coordinating Center, School of Public Health, University of North Carolina; 1987.

        • Crow R.S.
        • Prineas R.J.
        • Rautaharju P.
        • Hannan P.
        • Liebson P.R.
        Relation between electrocardiography and echocardiography for left ventricular mass in mild systolic hypertension (results from Treatment of Mild Hypertension Study).
        Am J Cardiol. 1995; 75: 1233-1238
        • Pignoli P.
        • Tremoli E.
        • Poli A.
        • Oreste P.
        • Paoletti R.
        Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging.
        Circulation. 1986; 74: 1399-1406
      6. National Heart, Lung, and Blood Institute. Atherosclerosis Risk in Communities (ARIC) Study. Operations manual no. 6A: ultrasound assessment—part A, ultrasound scanning, version 1.0. Chapel Hill, NC: ARIC Coordinating Center, School of Public Health, University of North Carolina; 1987.

        • Bond M.G.
        • Barnes R.W.
        • Riley W.A.
        • et al.
        • the ARIC Study Group
        High-resolution B-mode ultrasound scanning methods in the Atherosclerosis Risk in Communities Study (ARIC).
        J Neuroimaging. 1991; 1: 68-73
      7. National Heart, Lung, and Blood Institute. Atherosclerosis Risk in Communities (ARIC) Study. Operations manual no. 6B: ultrasound assessment—part A, ultrasound reading, version 1.0. Chapel Hill, NC: ARIC Coordinating Center, School of Public Health, University of North Carolina; 1987.

        • Chambless L.E.
        • Heiss G.
        • Folsom A.R.
        • et al.
        Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987–1993.
        Am J Epidemiol. 1997; 146: 483-894
        • Chambless L.E.
        • Heiss G.
        • Shahar E.
        • Earp M.J.
        • Toole J.
        Prediction of ischemic stroke risk in the Atherosclerosis Risk in Communities Study.
        Am J Epidemiol. 2004; 160: 259-269
      8. National Heart, Lung, and Blood Institute. Atherosclerosis Risk in Communities (ARIC) Study. Operations manual no. 3: surveillance component procedures, version 1.0. Chapel Hill, NC: ARIC Coordinating Center, School of Public Health, University of North Carolina; 1987.

        • Rosamond W.D.
        • Folsom A.R.
        • Chambless L.E.
        • et al.
        Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort.
        Stroke. 1999; 30: 736-743
      9. The National Survey of Stroke. National Institute of Neurological and Communicative Disorders and Stroke. Stroke 1981;12(2 Pt 2 Suppl. 1):I1–91.

        • Shahar E.
        • Chambless L.E.
        • Rosamond W.D.
        • et al.
        Plasma lipid profile and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study.
        Stroke. 2003; 34: 623-633
        • Klein B.E.
        • Klein R.
        • Lee K.E.
        Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam.
        Diabetes Care. 2002; 25: 1790-1794
        • Psaty B.M.
        • Lumley T.
        • Furberg C.D.
        • et al.
        Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.
        JAMA. 2003; 289: 2534-2544
        • ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group
        The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
        JAMA. 2002; 288: 2981-2997